Select Ongoing Trials Currently Enrolling Patients with Renal-Cell Carcinoma.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 2, p. 24
- Publication type:
- Article
Works matching IS 21644403 AND DT 2022 AND VI 12 AND IP 2
Results: 9
1
2
Support Services for Patients with Cancer Must Go Beyond Simply Building a HUB.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 2, p. 13
- By:
- Publication type:
- Article
3
The No Surprises Act: What Providers and Administrators Need to Know.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 2, p. 22
- By:
- Publication type:
- Article
4
Expert Perspective on the Evolving Standard of Care in Biliary Tract Cancers.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 2, p. 20
- By:
- Publication type:
- Article
5
Cervical Cancer Screening Rates on the Decline in the United States.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 2, p. 19
- Publication type:
- Article
6
Time-Limited Venetoclax-Based Combinations Show Efficacy in Fit Patients with Chronic Lymphocytic Leukemia.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 2, p. 17
- By:
- Publication type:
- Article
7
Polatuzumab Vedotin plus R-CHP Beats Standard R-CHOP for Frontline Treatment of DLBCL.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 2, p. 1
- By:
- Publication type:
- Article
8
New Policies Regarding Intravenous Iron Replacement Are Creating Conundrum for Providers and Payers.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 2, p. 1
- By:
- Publication type:
- Article
9
Oncology Pipeline Overview: Recent Approvals and Near-Term Drugs.
- Published in:
- 2022
- By:
- Publication type:
- Proceeding